Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-19
1992-08-18
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514383, 514384, 548252, 548253, 548254, 5482622, 5482642, 5482668, 5482682, 5482678, 5482694, A61K 3141, C07D24912, C07D24908
Patent
active
051400367
ABSTRACT:
A class of 1,3,5-trisubstituted-1,2,4-triazole compounds is described for use in treatment of circulatory disorders. Compounds of particular interest are angiotensin II antagonists of the formula ##STR1## wherein m is one; wherein R.sup.1 is selected from ethyl, n-propyl, isopropyl, butyl, isobutyl, tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, benzyl, cyclohexyl, cyclohexymethyl, 2-butenyl, 3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein R.sup.2 is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, 4-methylbutyl, tert-butyl, n-pentyl, neo-pentyl, 1-oxoethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl, 1,1-dimethoxypropyl, 1,1-dimethoxypentyl, halo, difluoromethyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 1,1-difluoro-3-cyclohexypropyl, 1,1-dimethoxybutyl, 1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, cyclohexanoyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and butylthio; wherein each of R.sup.3 through R.sup.11 is hydrido with the proviso that at least one of R.sup.5 and R.sup.9 must be selected from COOH, SH, PO.sub.3 H.sub.2, SO.sub.3 H, CONHNH.sub.2, CONHNHSO.sub.2 CF.sub.3, OH, ##STR2## wherein each of R.sup.42 and R.sup.43 is independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl. These compounds are particularly useful in treatment or control of hypertension and congestive heart failure.
REFERENCES:
patent: 3857845 (1974-12-01), Palazzo
patent: 4294972 (1981-10-01), Cassidy et al.
patent: 4816463 (1989-03-01), Blankley et al.
patent: 4880804 (1989-11-01), Carini et al.
Burger, A. Medicinal Chemistry, 2nd Ed. New York, pp. 565-571, 578-581, 600-601 (1960).
Denkewalter et al., Progress in Drug Research, vol. 10, pp. 510-512 (1966).
P. C. Wong et al., J. Pharmacol. Exp. Ther., 247(1), 1-7 (1988).
A. T. Chiu et al., European J. Pharmacol., 157, 13-21 (1988).
A. T. Chiu et al., J. Pharmacol. Exp. Ther., 250(3), 867-874 (1989).
G. D. Searle & Co.
Keane J. Timothy
Matukaitis Paul D.
Miltenberger Lenora A.
Morris Patricia L.
LandOfFree
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249273